A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation

British Journal of Haematology - Tập 138 Số 1 - Trang 82-93 - 2007
Robert A. Campbell1, Thomas Fischer1,2, Alisa S. Wolberg3,1
1Department of Pathology and Laboratory Medicine, University of North Carolina
2Francis Owen Blood Research Laboratory, University of North Carolina, Chapel Hill, NC, USA
3Carolina Cardiovascular Biology Center, University of North Carolina

Tóm tắt

SummaryRecombinant activated factor VII (NovoSeven, rFVIIa) is used to abrogate bleeding in haemophiliacs with inhibitors and is hypothesised to work by increasing activated factor X generation on the platelet surface. We hypothesised that rFVIIa activity could be increased by the co‐addition of platelet procoagulant surface. This study characterised the ability of a rehydrated, lyophilised (RL) platelet preparation to increase rFVIIa activity in haemophilic conditions. RL platelets supported thrombin generation in the presence of factors VIII and IX but, in the absence of factors VIII and IX, thrombin generation was significantly reduced. RL platelets supported rFVIIa‐mediated thrombin generation in a rFVIIa‐concentration dependent manner. In a cell‐based in vitro model of haemophilia, the presence of RL platelets increased the rFVIIa‐dependent thrombin generation rate 2.8‐fold compared with rFVIIa alone. Similarly, the addition of RL platelets plus rFVIIa to the in vitro model of haemophilia and to haemophilic platelet‐rich plasma shortened the onset of clot formation and increased clot stability in a fibrinolytic environment versus rFVIIa alone. These results suggest that RL platelets can support rFVIIa‐mediated thrombin generation, and that co‐administration of RL platelets with rFVIIa may increase the efficacy of rFVIIa in some patients.

Từ khóa


Tài liệu tham khảo

10.1182/blood.V95.5.1694.005k24_1694_1702

10.1111/j.1538-7933.2003.00617.x

10.1161/01.ATV.0000257204.82396.2b

10.1111/j.1423-0410.1986.tb01972.x

10.1016/S0955-3886(00)00028-X

10.1182/blood.V70.2.490.490

10.1046/j.1537-2995.1996.36696269513.x

10.1046/j.1538-7836.2004.00710.x

10.1111/j.1365-2141.2000.02343.x

10.1081/BIO-100108549

10.1080/1024533021000047954

10.1111/j.1538-7836.2004.01015.x

10.1097/00001721-200004001-00020

10.1055/s-0037-1613160

10.1002/jlb.48.2.156

10.1093/ajcp/98.5.531

Hoffman M., 1995, Factors IXa and Xa play distinct roles in tissue factor‐dependent initiation of coagulation, Blood, 86, 1794, 10.1182/blood.V86.5.1794.bloodjournal8651794

10.1016/S0049-3848(00)00308-X

Jones A.J., 1990, A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis, Thrombosis and Haemostasis, 64, 455, 10.1055/s-0038-1647336

10.1046/j.1365-2141.2001.02870.x

10.1046/j.1537-2995.1997.37397240206.x

10.1038/4795

10.1038/clpt.1994.80

10.1111/j.1538-7836.2005.01683.x

10.1182/blood.V88.9.3456.bloodjournal8893456

10.1046/j.1365-2141.1997.4463256.x

10.1073/pnas.92.2.397

Saxena K., 2006, Coated‐platelet levels may explain some variability in clinical phenotype of severe hemophilia, Blood (ASH Annual Meeting Abstracts), 108, 1018

10.1080/0953710031000154722

10.1111/j.1365-2141.1976.tb03587.x

10.1053/j.seminhematol.2003.11.026

10.1111/j.1423-0410.2005.00592.x

10.1097/00001721-200209000-00008

10.1182/blood-2002-08-2527

10.1111/j.1365-2141.2005.05820.x

10.1016/j.thromres.2005.04.030

10.1042/BJ20050029